Details for New Drug Application (NDA): 216925
✉ Email this page to a colleague
The generic ingredient in CHLORZOXAZONE is chlorzoxazone. There are sixteen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the chlorzoxazone profile page.
Summary for 216925
Tradename: | CHLORZOXAZONE |
Applicant: | Graviti Pharms |
Ingredient: | chlorzoxazone |
Patents: | 0 |
Pharmacology for NDA: 216925
Physiological Effect | Centrally-mediated Muscle Relaxation |
Medical Subject Heading (MeSH) Categories for 216925
Suppliers and Packaging for NDA: 216925
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CHLORZOXAZONE | chlorzoxazone | TABLET;ORAL | 216925 | ANDA | Rising Pharma Holdings, Inc. | 64980-582 | 64980-582-06 | 60 TABLET in 1 BOTTLE (64980-582-06) |
CHLORZOXAZONE | chlorzoxazone | TABLET;ORAL | 216925 | ANDA | Graviti Pharmaceuticals Private Limited | 69844-054 | 69844-054-01 | 60 TABLET in 1 BOTTLE (69844-054-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 250MG | ||||
Approval Date: | Aug 9, 2023 | TE: | AA | RLD: | No |
Complete Access Available with Subscription